Patient burden associated with acute & chronic resistant infections
Inspiring stakeholders to take action on antimicrobial resistance (AMR) starts with communicating the current and future burden of...
Engagements
Value proposition development for a phase 3 neuroscience asset
Related insights
Upcoming events
6th ESCMID Conference on Vaccines "From development to real-world clinical practice and global health"
Abhishek Kumar presents his poster titled “Top Trends Affecting the Vaccines Market and their Implications on Access Policy and Public Health...
IP Watchdog: 4th Annual Life Sciences Masters™ 2025
CRA is a proud sponsor of the conference focusing on the intersection of intellectual property and the biopharmaceutical industry, and will explore the law,...